Cita APA

Moll, G., Drzeniek, N., Kamhieh-Milz, J., Geissler, S., Volk, H., & Reinke, P. (2020). MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy. Front Immunol.

Citación estilo Chicago

Moll, Guido, Norman Drzeniek, Julian Kamhieh-Milz, Sven Geissler, Hans-Dieter Volk, y Petra Reinke. "MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy." Front Immunol 2020.

Cita MLA

Moll, Guido, et al. "MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy." Front Immunol 2020.